南都物業(603506.SH):擬向雲象機器人增資1500萬元
格隆匯4月7日丨南都物業(603506.SH)公佈,本輪投資擬向雲象機器人增資合計人民幣1,500萬元,本次增資完成後,南都物業持有標的公司8.5714%股權,標的公司控制權未發生改變。本次交易完成後,雲象機器人將成爲公司的參股公司,公司與雲象機器人業務的協同合作能否順利實施以及效果能否達到預期存在一定的不確定性。
雲象機器人是一家專注於商用清潔領域的機器人公司,在視覺感知、深度學習、自主決策等領域具備技術優勢,旗下產品已在工廠車間、地下車庫、機場車站、商超百貨、政務辦公、物流倉儲、寫字樓、展館、醫院、學校、酒店等各種工商業態場景應用,尤其是在
AGV
混合調度場景,處於業內領先地位。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.